ALK GBSC
About Us
News
Careers
Contact
Zgłaszanie działań niepożądanych
Fulltext search
Search
ACARIZAX® approved in Canada for treatment of young children
Link
https://www.globenewswire.com/news-release/2025/03/07/3038942/0/en/ACARIZAX-app…
Created date
Fri, 03/07/2025 - 12:00
Nasdaq ID
3038942
Last updated:
2025.03.07
